₹ 49
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Oxygenta Pharmaceutical Ltd. focuses on the formulation and production of active pharmaceutical ingredients. Their offerings specifically encompass medications used to treat ulcers and fight bacterial infections. The company commenced operations on November 27, 1990, and maintains its primary base in Hyderabad, India.
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers.
Data is available to registered users only